The government proposed amendments that would set up an inventory control mechanism to prevent panic buying and drug hoarding following the planned withdrawal of some drugs from the Taiwanese market, Minister of Health and Welfare Shih Chung-liang (石崇良) said yesterday.
Food and Drug Administration (FDA) data showed that as of the end of last month, 47 drugs are to be withdrawn from the Taiwanese market.
Most of these drugs have alternative options, the FDA said, adding that 25 share the same ingredients, dosages and dosage forms with other generic drugs, and 21 have substitutes with the same ingredients or mechanisms.
Photo: Chung Li-hua, Taipei Times
Only one drug would stop production by the end of next year, it said.
Shih yesterday said that the FDA has submitted proposed amendments to the Pharmaceutical Affairs Act (藥事法), which would require pharmaceutical companies to report plans to discontinue a drug’s production at least six months in advance.
The amendment also seeks to authorize the FDA to control the inventory of drugs when facing a supply shortage, he said, adding that the ministry plans to initiate a special drug import project in response to the planned discontinuation of an immunosuppressive drug next year.
Although pharmaceutical companies reported that supplies of the 47 drugs would be unstable over the next six months due to reduced production or plans to exit the market, only immunosuppressive agent cyclosporine would stop being produced, Shih said.
The company would continue to supply the drug until the end of the year, he said.
Companies that produce essential medicines must report to the FDA six months in advance if they plan to reduce production or withdraw from the market, but that is not mandatory for non-essential drugs, Shih said.
Sometimes those are reported at short notice, leaving the FDA with very limited time to assess and respond to the situation, he added.
The proposed amendment includes three main points, Shih said.
First, companies that produce any type of drug would be required to report to the FDA plans to reduce or stop production at least six months in advance.
Second, the FDA would be authorized to oversee inventory control when a drug is facing potential supply shortage due to discontinuation or lower production.
Hospitals often scramble to stock up on those drugs, causing other hospitals or pharmacies to experience a shortage earlier, he said.
Third, companies would be asked whether they want to adjust their drug prices.
The National Health Insurance Administration had asked the companies producing the 47 drugs if they want to change their prices, but they said their plan to discontinue supply was due to global supply readjustment, not pricing, Shih said.
Faced with potential drug price increases due to US President Donald Trump’s new tariffs, the special resilience act has allocated NT$20 billion (US$654.8 million) for drug price adjustments, he said.
However, for long-term drug industry resilience, the military must boost the public’s confidence in generic drugs, he added.
Additional reporting by Chiu Chih-jou
The Republic of China (ROC) is celebrating its 114th Double Ten National Day today, featuring military parades and a variety of performances and speeches in front of the Presidential Office in Taipei. The Taiwan Taiko Association opened the celebrations with a 100-drummer performance, including young percussionists. As per tradition, an air force Mirage 2000 fighter jet flew over the Presidential Office as a part of the performance. The Honor Guards of the ROC and its marching band also heralded in a military parade. Students from Taichung's Shin Min High School then followed with a colorful performance using floral imagery to represent Taiwan's alternate name
COGNITIVE WARFARE: Chinese fishing boats transmitting fake identification signals are meant to test Taiwan’s responses to different kinds of perceived incursions, a report said Chinese vessels are transmitting fake signals in Taiwan’s waters as a form of cognitive warfare, testing Taipei’s responses to various types of incursions, a report by the Institute for the Study of War said on Friday. Several Chinese fishing vessels transmitted fake automatic identification system (AIS) signals in Taiwan’s waters last month, with one mimicking a Russian warship and another impersonating a Chinese law enforcement vessel, the report said. Citing data from Starboard Maritime Intelligence, the report said that throughout August and last month, the Chinese fishing boat Minshiyu 06718 (閩獅漁06718) sailed through the Taiwan Strait while intermittently transmitting its own AIS
CHINESE INFILTRATION: Medical logistics is a lifeline during wartime and the reported CCP links of a major logistics company present a national security threat, an expert said The government would bolster its security check system to prevent China from infiltrating the nation’s medical cold chain, a national security official said yesterday. The official, who wished to stay anonymous, made the remarks after the Chinese-language magazine Mirror Media (鏡周刊) reported that Pharma Logistics (嘉里醫藥物流) is in charge of the medical logistics of about half of the nation’s major hospitals, including National Taiwan University Hospital and Taipei Veterans General Hospital. The company’s parent, Kerry TJ Logistics Co (嘉里大榮物流), is associated with the National Committee of the Chinese People’s Political Consultative Conference (CPPCC) and the Chinese People’s Liberation Army (PLA), the
COVETED PRIZE: The US president would be a peace prize laureate should he persuade Xi Jinping to abandon military aggression against Taiwan, William Lai said US President Donald Trump should get the Nobel Peace Prize should he be able to convince Chinese President Xi Jinping (習近平) to abandon the use of force against Taiwan, President William Lai (賴清德) told a conservative US radio show and podcast in an interview. The US is Taiwan’s most important international backer, despite the absence of formal ties, but since Trump took office earlier this year he has not announced any new arms sales to the nation. Trump could meet Xi at the APEC summit in South Korea on Oct. 31 and Nov. 1. Lai, speaking on The Clay Travis and Buck Sexton
RSS